Welcome to our dedicated page for NORTHROP GRUMMAN /DE/ SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NORTHROP GRUMMAN /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NORTHROP GRUMMAN /DE/'s regulatory disclosures and financial reporting.
Northrop Grumman Corporation corporate vice president and general counsel Kathryn G. Simpson reported an open-market sale of common stock. On March 2, 2026, she sold 873 shares of Northrop Grumman common stock at a price of $745.00 per share, in a transaction classified as a non-derivative sale. The filing notes that this sale was executed under a pre-established Rule 10b5-1 trading plan adopted on February 28, 2025. Following the sale, Simpson directly held 1.39 shares of Northrop Grumman common stock.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported an open-market sale of 1,754 shares of common stock at $720 per share on February 27, 2026. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on October 30, 2025. After the transaction, Roeder directly held 2,353.390 shares, plus an additional 116.7023 shares held indirectly in the Northrop Grumman Savings Plan as of February 27, 2026.
Northrop Grumman (NOC) related filing reports a proposed sale of 873 common shares following restricted stock vesting, with the transaction dated 02/11/2026.
The excerpt also discloses recent selling activity by Kathryn Simpson: 779 shares for $547,294.24 on 02/17/2026 and 194 shares for $141,158.28 on 02/19/2026. The sales are identified as related to compensation and restricted stock vesting.
Northrop Grumman Corporation filed a Form 144 reporting a proposed sale of 1,754 common shares related to restricted stock vesting on 02/11/2026.
Recent sale activity by Roshan Roeder is shown as examples: 84 shares on 12/09/2025 ($46,649.40), 318 shares on 02/17/2026 ($223,414.08), and 512 shares on 02/19/2026 ($372,541.44).
Northrop Grumman’s Corporate Vice President and General Counsel, Kathryn G. Simpson, reported an open-market sale of 194 shares of common stock on February 19, 2026. The shares were sold at an average price of $727.62 per share, and she held 874.39 shares directly afterward.
The filing notes that this sale was carried out under a pre-established Rule 10b5-1 trading plan, which Simpson adopted on February 28, 2025. Such plans are designed to systematically execute trades over time, helping insiders diversify holdings while reducing concerns about trading on nonpublic information.
Northrop Grumman Corporation executive Roshan S. Roeder, CVP & President of Mission Systems, sold 512 shares of common stock in an open-market transaction on February 19, 2026 at an average price of $727.62 per share. This sale, totaling roughly $372,000, was executed under a pre-established Rule 10b5-1 trading plan adopted on October 30, 2025. After the sale, Roeder directly held 4,107.39 shares of common stock and had an additional 115.9204 shares held indirectly in the Northrop Grumman Savings Plan, where balances are based on units that can change without an actual share acquisition or disposition.
Northrop Grumman Corp (NOC) insider Michael A. Hardesty, Corporate Vice President, Controller and Chief Accounting Officer, reported an open-market sale of common stock. He sold 147 shares of Northrop Grumman common stock at a price of $732.98 per share on February 19, 2026. Following this transaction, he directly owns 2,525.29 shares of the company’s common stock.
Northrop Grumman director Christopher W. Grady reported an equity award of common stock under the company’s long-term incentive program. On February 12, 2026, he acquired 71 shares of common stock at a reported price of $695.06 per share in a transaction categorized as a grant or award.
According to the disclosure, these shares were deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this award, Grady’s directly held stock unit account reflected 71 shares of common stock equivalents pursuant to the plan.
Northrop Grumman director Christopher W. Grady filed an initial ownership report showing no direct holdings of the company’s common stock. The Form 3 indicates that, following the reported position, he owned 0 shares of Northrop Grumman common stock directly and reported no purchase or sale activity in this filing.
Northrop Grumman executive Benjamin R. Davies, Corporate Vice President and President of Defense Systems, reported several stock transactions. He sold 2,189.04 shares of common stock in an open‑market sale at a weighted average price of $719.61 per share, leaving 151 shares held directly.
On the prior day, 274 restricted stock rights were exercised into the same number of common shares, and 123 shares were withheld at $701.12 per share to cover tax obligations. Davies now holds 6,444 restricted stock rights that are scheduled to vest in stages between 2026 and 2029.